InvestorsHub Logo
Followers 0
Posts 93
Boards Moderated 0
Alias Born 01/11/2004

Re: altarboy4 post# 114

Thursday, 08/17/2006 12:16:23 AM

Thursday, August 17, 2006 12:16:23 AM

Post# of 303
You might be thinking of this:

"On January 21, 2006 the Company entered into a subscription agreement (the "Subscription") with SKL Family Limited Partnership, LP, a New Jersey limited partnership, whereby SKL purchased 2.0 million shares (the "Subscription Shares") of the Company's common stock at a purchase price of $0.20/share for $400,000. Under the terms of the Subscription, the Subscription Shares are restricted for a period of 24 months and then carry piggyback registration rights to the extent that exemptions under Rule 144 are not available to SKL. In connection with the Subscription, the Company also issued a five year warrant to purchase 900,000 shares of the Company's common stock at an exercise price of $0.26/share. SKL has no previous affiliation with the Company.

On March 14, 2006, Aspen exercised its Equity Purchase Rights and we issued to Aspen 1,000,000 restricted shares of common stock at a purchase price of $0.20/share for $200,000. In connection with this transaction, the Company also issued a five year warrant to purchase 450,000 shares of common stock at an exercise price of $0.26/share."
,

What I don't like -and it appears very suspicious, in my opinion- is the stock got pounded down to 12 cents before that special 20 cent deal for SKL. Someone really was hitting the stock hard taking it down to 12 cents and I couldn't figure out why...everyone knew NGNM was coming out of the red and becoming profitable so why would someone pound the stock down to pennies...I think it's obvious...

Gasparini grew annual revenue in his previous company to 30 million in just 30 months...looks like he is going to do the same again. I would imagine he'll need to get annual revenue up into 100 million and more before we see the kind of share price you envision or if they were to start some research projects that could also accelerate the stock price. Anything is possible, I've learned. This is an exciting stock to be holding.

Gasparini signed a 3 year contract with Neogenomics and if he should not renew for some reason...it would be time to sell.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NEO News